A Randomized Phase III Trial of Optimal Sequencing of Hormone Therapy and Radiation Therapy in Patients with T1-T3 Prostate Cancer
The study is designed to evaluate the optimal sequencing of radiation therapy and hormonal therapy in the treatment of patients with carcinoma of the prostate. Patients with cT1-T3N0M0 prostate cancer will be randomized to early versus delayed radiation therapy regimen in combination with 6 months of hormonal therapy. The main objective of this trial is to assess the optimal timing of radiation therapy on various clinical outcomes.
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society